EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates

Parham Ramezani-Rad, Ester Marina-Zárate, Laura Maiorino, Amber Myers, Katarzyna Kaczmarek Michaels, Ivan S Pires, Nathaniel I Bloom, Mariane B Melo, Ashley A Lemnios, Paul G Lopez, Christopher A Cottrell, Iszac Burton und 16 weitere

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci185292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Parham Ramezani-Rad und 27 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, USA. Hauptthemen laut MEDLINE: AIDS Vaccines, Nanoparticles, Saponins, Lipid A. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Induction of durable protective immune responses is the main goal of prophylactic vaccines, and adjuvants play a role as drivers of such responses. Despite advances in vaccine strategies, development of a safe and effective HIV vaccine remains a significant challenge. Use of an appropriate adjuvant is crucial to the success of HIV vaccines. Here we assessed the saponin/MPLA nanoparticle (SMNP) adjuvant with an HIV envelope (Env) trimer, evaluating the safety and effect of multiple variables — including adjuvant dose (16-fold dose range), immunization route, and adjuvant composition — on the establishment of Env-specific memory T and B cell (T Mem and B Mem ) responses and long-lived plasma cells in nonhuman primates (NHPs). Robust B Mem were detected in all groups, but a 6-fold increase was observed in the highest- versus the lowest-SMNP-dose group. Similarly, stronger vaccine responses were induced by the highest SMNP dose in CD40L + OX40 + CD4 + T Mem (11-fold), IFN-γ + CD4 + T Mem (15-fold), IL21 + CD4 + T Mem (9-fold), circulating T follicular helper cells (T FH ; 3.6-fold), BM plasma cells (7-fold), and binding IgG (1.3-fold). Substantial tier 2 neutralizing antibodies were only observed in the higher-SMNP-dose groups. These investigations highlight the dose-dependent potency of SMNP and its relevance for human use and next-generation vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AIDS VaccinesNanoparticlesSaponinsLipid AAdjuvants, ImmunologicHIV-1HIV InfectionsAnimalsMacaca mulattaFemaleHIV AntibodiesB-Lymphocytes

Stichwörter der Autor:innen

AIDS vaccineAIDS/HIVAdaptive immunityImmunology

Substanzen

AIDS VaccinesSaponinsmonophosphoryl lipid ALipid AAdjuvants, ImmunologicHIV Antibodies

Autor:innen und Institutionen

  • Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, USA.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA.
  • Emory National Primate Research Center and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Polymun Scientific Immunbiologische Forschung GmbH, Klosterneuburg, Austria.

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • NIH

Zitieren

APA

Ramezani-Rad, P., Marina-Zárate, E., Maiorino, L., Myers, A., Kaczmarek Michaels, K., Pires, I. S., Bloom, N. I., Melo, M. B., Lemnios, A. A., Lopez, P. G., Cottrell, C. A., Burton, I., Groschel, B., Pradhan, A., Stiegler, G., Budai, M., Kumar, D., Pallerla, S., Sayeed, E., …, & Irvine, D. J. (2025). The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates. Journal of Clinical Investigation. https://doi.org/10.1172/jci185292

Vancouver

Ramezani-Rad P, Marina-Zárate E, Maiorino L, Myers A, Kaczmarek Michaels K, Pires IS, et al. The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates. Journal of Clinical Investigation. 2025. doi:10.1172/jci185292

BibTeX
@article{RamezaniRad2025,
  author = {Ramezani-Rad, Parham and Marina-Zárate, Ester and Maiorino, Laura and Myers, Amber and Kaczmarek Michaels, Katarzyna and Pires, Ivan S and Bloom, Nathaniel I and Melo, Mariane B and Lemnios, Ashley A and Lopez, Paul G and Cottrell, Christopher A and Burton, Iszac and Groschel, Bettina and Pradhan, Arpan and Stiegler, Gabriela and Budai, Magdolna and Kumar, Daniel and Pallerla, Sam and Sayeed, Eddy and Sagar, Sangeetha L and Kasturi, Sudhir Pai and Van Rompay, Koen Ka and Hangartner, Lars and Wagner, Andreas and Burton, Dennis R and Schief, William R and Crotty, Shane and Irvine, Darrell J},
  title = {The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci185292}
}
Kostenlos starten →